“BF-200 ALA for the Photodynamic Treatment of Non-Aggressive Basal Cell Carcinoma: Results of a Phase III Comparator Trial” (2017) SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s112. doi:10.25251/skin.1.supp.111.